Topic
pharmacology research, explained
5 open-access pharmacology studies, each with a flashcard deck and a quiz.
- Which Indian traditional medicines are being eyed for COVID-19?
This review prioritizes AYUSH formulations and Indian plants with antiviral, immunomodulatory, and anti-inflammatory records for COVID-19 testing amid India’s then-<1.5% case fatality narrative.
- What’s being done for T2DM care across Africa?
With ~19M adults with diabetes (→47M by 2045 if unchecked), African systems are expanding diagnosis/adherence programs—but major gaps remain, especially with HIV/TB co-morbidity.
- Can a hydrogen sulfide donor protect the liver from cyclophosphamide?
In rats, 10-day NaHS pretreatment lowered CP-driven ALT/AST spikes and suppressed TLR2/4–JNK/NF-κB inflammatory signaling linked to hepatotoxicity.
- Do GLP-1 drugs help as add-ons in type 1 diabetes?
Across 11 RCTs (2,856 adults), GLP-1 RA add-on therapy modestly lowered HbA1c (−0.21%), weight (−4.04 kg), and insulin doses without more severe hypo/DKA, but GI adverse events rose (OR 2.96).
- Do amygdala astrocytes help or hurt chronic neuropathic pain?
CeA GFAP rose at 4 weeks (not 1 week) after SNL; inhibiting astrocytes with FCA increased CeLC excitability and facilitated mechanical/affective pain behaviors, suggesting beneficial astrocyte roles.